Lineage Cell Therapeutics Cash from Financing (TTM) Insights

Lineage Cell Therapeutics Inc (LCTX)

1.17 -0.01 (-0.85%) USD | NYAM | May 10, 16:00

1.17 0.00 (0.00%) After-Hours: 16:25

Cash from Financing (TTM) Chart

Historical Cash from Financing (TTM) Data

View and export this data back to 1993. Upgrade now.

Date	Value
December 31, 2023	6.423M
September 30, 2023	6.558M
June 30, 2023	6.715M
March 31, 2023	1.12M
December 31, 2022	1.632M
September 30, 2022	2.464M
June 30, 2022	5.219M
March 31, 2022	16.48M
December 31, 2021	36.93M
September 30, 2021	40.79M
June 30, 2021	61.63M
March 31, 2021	50.84M
December 31, 2020	29.86M
September 30, 2020	25.05M
June 30, 2020	0.567M
March 31, 2020	0.001M
December 31, 2019	0.617M
September 30, 2019	0.716M
June 30, 2019	0.782M
March 31, 2019	5.747M
December 31, 2018	5.774M
September 30, 2018	32.06M
June 30, 2018	36.91M
March 31, 2018	36.93M
December 31, 2017	55.39M

Date	Value
September 30, 2017	29.86M
June 30, 2017	37.07M
March 31, 2017	51.12M
December 31, 2016	32.78M
September 30, 2016	61.48M
June 30, 2016	60.43M
March 31, 2016	59.86M
December 31, 2015	64.78M
September 30, 2015	66.20M
June 30, 2015	55.50M
March 31, 2015	57.18M
December 31, 2014	63.62M
September 30, 2014	41.78M
June 30, 2014	41.32M
March 31, 2014	33.28M
December 31, 2013	34.26M
September 30, 2013	26.76M
June 30, 2013	27.04M
March 31, 2013	15.03M
December 31, 2012	1.913M
September 30, 2012	0.2873M
June 30, 2012	3.050M
March 31, 2012	3.173M
December 31, 2011	3.862M
September 30, 2011	10.96M

Cash From Financing Definition

Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.

Read full definition.

Cash from Financing (TTM) Range, Past 5 Years

0.001M

Minimum

Mar 2020

61.63M

Maximum

Jun 2021

15.49M

Average

6.423M

Median

Dec 2023

Cash from Financing (TTM) Benchmarks